CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2590
-0.0078 (-2.92%)
Oct 20, 2025, 3:58 PM EDT
CytoDyn Balance Sheet
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 31, 2025 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 9.33 | 11.9 | 3.11 | 2.54 | 4.23 | 33.94 | Upgrade |
Cash & Short-Term Investments | 9.33 | 11.9 | 3.11 | 2.54 | 4.23 | 33.94 | Upgrade |
Cash Growth | -62.55% | 282.73% | 22.39% | -39.94% | -87.53% | 137.66% | Upgrade |
Other Receivables | - | 2 | - | - | - | - | Upgrade |
Receivables | - | 2 | - | - | - | - | Upgrade |
Prepaid Expenses | 0.56 | 0.25 | 0.46 | 1.17 | 5.2 | 0.62 | Upgrade |
Restricted Cash | - | - | 6.7 | 6.51 | - | - | Upgrade |
Other Current Assets | 3.46 | 3.72 | 0.54 | 0.59 | 1.09 | 1.54 | Upgrade |
Total Current Assets | 13.35 | 17.88 | 10.82 | 10.81 | 10.52 | 36.1 | Upgrade |
Property, Plant & Equipment | 0.1 | 0.13 | 0.26 | 0.4 | 0.54 | 0.85 | Upgrade |
Other Intangible Assets | - | - | - | - | - | 1.65 | Upgrade |
Other Long-Term Assets | 0.04 | 0.04 | 0.06 | 0.09 | 18.13 | 93.48 | Upgrade |
Total Assets | 13.48 | 18.05 | 11.14 | 11.29 | 29.19 | 132.08 | Upgrade |
Accounts Payable | 14.18 | 14.69 | 29.56 | 62.73 | 67.97 | 65.9 | Upgrade |
Accrued Expenses | 19.3 | 20.22 | 17.6 | 17.13 | 14.84 | 21.08 | Upgrade |
Current Portion of Long-Term Debt | 27.2 | 27.2 | 29.79 | 34.42 | 36.24 | 62.75 | Upgrade |
Current Portion of Leases | 0.11 | 0.14 | 0.14 | 0.14 | 0.13 | 0.18 | Upgrade |
Other Current Liabilities | 8.64 | 8.27 | 7.09 | 5.39 | 3.98 | 2.65 | Upgrade |
Total Current Liabilities | 69.42 | 70.52 | 84.18 | 119.8 | 123.16 | 152.55 | Upgrade |
Long-Term Debt | - | - | - | 0.71 | - | - | Upgrade |
Long-Term Leases | - | - | 0.14 | 0.28 | 0.42 | 0.55 | Upgrade |
Other Long-Term Liabilities | 43.57 | 43.57 | 43.57 | - | - | - | Upgrade |
Total Liabilities | 112.99 | 114.09 | 127.89 | 120.79 | 123.58 | 153.1 | Upgrade |
Common Stock | 1.26 | 1.25 | 1.06 | 0.92 | 0.72 | 0.63 | Upgrade |
Additional Paid-In Capital | 792.56 | 790.5 | 773.71 | 731.27 | 671.01 | 532.03 | Upgrade |
Retained Earnings | -893.33 | -887.79 | -891.53 | -841.69 | -766.13 | -553.68 | Upgrade |
Total Common Equity | -99.51 | -96.04 | -116.76 | -109.5 | -94.4 | -21.02 | Upgrade |
Shareholders' Equity | -99.51 | -96.04 | -116.76 | -109.5 | -94.4 | -21.02 | Upgrade |
Total Liabilities & Equity | 13.48 | 18.05 | 11.14 | 11.29 | 29.19 | 132.08 | Upgrade |
Total Debt | 27.31 | 27.34 | 30.08 | 35.55 | 36.8 | 63.47 | Upgrade |
Net Cash (Debt) | -17.97 | -15.44 | -26.97 | -33.01 | -32.57 | -29.53 | Upgrade |
Net Cash Per Share | -0.01 | -0.01 | -0.03 | -0.04 | -0.05 | -0.05 | Upgrade |
Filing Date Shares Outstanding | 1,260 | 1,251 | 1,214 | 930.52 | 810.28 | 632.14 | Upgrade |
Total Common Shares Outstanding | 1,257 | 1,249 | 1,059 | 918.61 | 719.59 | 625.68 | Upgrade |
Working Capital | -56.07 | -52.64 | -73.37 | -108.99 | -112.65 | -116.44 | Upgrade |
Book Value Per Share | -0.08 | -0.08 | -0.11 | -0.12 | -0.13 | -0.03 | Upgrade |
Tangible Book Value | -99.51 | -96.04 | -116.76 | -109.5 | -94.4 | -22.67 | Upgrade |
Tangible Book Value Per Share | -0.08 | -0.08 | -0.11 | -0.12 | -0.13 | -0.04 | Upgrade |
Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.